Results from the single-arm FROZEN AF study of Boston Scientific’s POLARx cryoablation system met the safety and effectiveness endpoints and will support a premarket approval application to the FDA.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?